James BR - Search Results

1

Cutting Edge: Elevated Leptin during Diet-Induced Obesity Reduces the Efficacy of Tumor Immunotherapy.

Murphy KA, James BR, Sjaastad FV, Kucaba TA, Kim H, Brincks EL, Chua SC Jr, Wilber A, Griffith TS. Murphy KA, et al. Among authors: james br. J Immunol. 2018 Oct 1;201(7):1837-1841. doi: 10.4049/jimmunol.1701738. Epub 2018 Aug 22. J Immunol. 2018. PMID: 30135180 Free PMC article.

2

Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth.

James BR, Tomanek-Chalkley A, Askeland EJ, Kucaba T, Griffith TS, Norian LA. James BR, et al. J Immunol. 2012 Aug 1;189(3):1311-21. doi: 10.4049/jimmunol.1100587. Epub 2012 Jun 27. J Immunol. 2012. PMID: 22745381 Free PMC article.

3

Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cells.

James BR, Brincks EL, Kucaba TA, Boon L, Griffith TS. James BR, et al. Cancer Immunol Immunother. 2014 Jul;63(7):685-97. doi: 10.1007/s00262-014-1548-5. Epub 2014 Apr 8. Cancer Immunol Immunother. 2014. PMID: 24711083 Free PMC article.

4

CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.

James BR, Anderson KG, Brincks EL, Kucaba TA, Norian LA, Masopust D, Griffith TS. James BR, et al. Cancer Immunol Immunother. 2014 Nov;63(11):1213-27. doi: 10.1007/s00262-014-1598-8. Epub 2014 Aug 21. Cancer Immunol Immunother. 2014. PMID: 25143233 Free PMC article.

5

Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge.

Cabrera-Perez J, Condotta SA, James BR, Kashem SW, Brincks EL, Rai D, Kucaba TA, Badovinac VP, Griffith TS. Cabrera-Perez J, et al. Among authors: james br. J Immunol. 2015 Feb 15;194(4):1609-20. doi: 10.4049/jimmunol.1401711. Epub 2015 Jan 16. J Immunol. 2015. PMID: 25595784 Free PMC article.

6

Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.

Brincks EL, Kucaba TA, James BR, Murphy KA, Schwertfeger KL, Sangwan V, Banerjee S, Saluja AK, Griffith TS. Brincks EL, et al. Among authors: james br. FEBS J. 2015 Dec;282(24):4747-4765. doi: 10.1111/febs.13532. Epub 2015 Oct 18. FEBS J. 2015. PMID: 26426449 Free PMC article.

7

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies.

Murphy KA, James BR, Wilber A, Griffith TS. Murphy KA, et al. Among authors: james br. J Vis Exp. 2017 Apr 12;(122):55080. doi: 10.3791/55080. J Vis Exp. 2017. PMID: 28448047 Free PMC article.

8

Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy.

Norian LA, Kresowik TP, Rosevear HM, James BR, Rosean TR, Lightfoot AJ, Kucaba TA, Schwarz C, Weydert CJ, Henry MD, Griffith TS. Norian LA, et al. Among authors: james br. PLoS One. 2012;7(2):e31085. doi: 10.1371/journal.pone.0031085. Epub 2012 Feb 1. PLoS One. 2012. PMID: 22312440 Free PMC article.

9

Activation of systemic antitumor immunity via TRAIL-induced apoptosis.

James BR, Griffith TS. James BR, et al. Oncoimmunology. 2012 Oct 1;1(7):1178-1180. doi: 10.4161/onci.20638. Oncoimmunology. 2012. PMID: 23170271 Free PMC article.

10

Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma.

Murphy KA, James BR, Guan Y, Torry DS, Wilber A, Griffith TS. Murphy KA, et al. Among authors: james br. Hum Vaccin Immunother. 2015;11(7):1612-20. doi: 10.1080/21645515.2015.1035849. Hum Vaccin Immunother. 2015. PMID: 25996049 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters